For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Epix Pharmaceuticals, Inc.

USPTO Granted Patents = 14

% Expired Patents = 71.4

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 124

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Thomas J McMurry (6 out of 15 patents)

Randall B Lauffer (6 out of 22 patents)

Xiang Y Yu (4 out of 35 patents)

4. Daniel M Scott (4 out of 27 patents)

5. Jian Lin (3 out of 48 patents)

6. Yael Marantz (3 out of 18 patents)

7. Oren Becker (3 out of 27 patents)

8. Ashis K Saha (3 out of 22 patents)

9. Nili Schutz (3 out of 5 patents)

10. Mercedes Lobera (3 out of 11 patents)

11. Hironao Sijiki (3 out of 6 patents)

12. Robert M Weisskoff (3 out of 5 patents)

13. Srinivasa Rao Cheruku (3 out of 19 patents)

14. Victor J Cee (2 out of 37 patents)

15. Peter Caravan (2 out of 17 patents)

14 patents: Sort by Forward Citations

1. 8080542 - S1P receptor modulating compounds and use thereof (2011-12-20),

2. 7919519 - S1P receptor modulating compounds and use thereof (2011-04-05),

3. 7855193 - S1P receptor modulating compounds and use thereof (2010-12-21),

4. 7790707 - S1P receptor modulating compounds and use thereof (2010-09-07),

5. 7412279 - Systems and methods for targeted magnetic resonance imaging of the vascular system (2008-08-12),

6. 7238341 - Peptide-based multimeric targeted contrast agents (2007-07-03),

7. 7229606 - Diagnostic imaging contrast agents with extended blood retention (2007-06-12),

8. 7186797 - Polypeptide conjugates with extended circulating half-lives (2007-03-06),

9. 7175829 - Contrast-enhanced diagnostic imaging method for monitoring interventional therapies (2007-02-13),

10. 7147837 - Bioactivated diagnostic imaging constrast agents (2006-12-12),

11. 7060250 - Diagnostic imaging contrast agents with extended blood retention (2006-06-13),

12. 7011815 - Diagnostic imaging contrast agents with extended blood retention (2006-03-14),

13. 6969507 - Imaging sexual response (2005-11-29),

14. 6925321 - Magnetic resonance angiography data (2005-08-02),

Epix Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases. With a dedicated team of researchers and scientists, Epix is committed to advancing healthcare through innovative approaches. Our mission is to improve patients' lives by delivering effective and safe pharmaceutical solutions. For more information about our company, products, and latest developments, please visit our website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

14 Patents

#49 in Lexington, MA

#1,359 in Massachusetts

#22,273 in US

#42,135 in the World

Lexington, MA, United States of America

Epix Pharmaceuticals, Inc.

Forward Citations = 124

40 inventors:

Thomas J McMurry (6 out of 15 patents)

Randall B Lauffer (6 out of 22 patents)

Xiang Y Yu (4 out of 35 patents)

4. Daniel M Scott (4 out of 27 patents)

5. Jian Lin (3 out of 48 patents)

Please report any incorrect information to [email protected]

Loading…